
NRX Pharmaceuticals (NRXP) Earnings Dates & Reports
NRX Pharmaceuticals (NRXP) Most Recent Earnings
Report DateAug 20, 2025
Period EndingQ2 2025
Est. EPS-$0.23
Actual EPS-$0.98
EarningsMiss
NRX Pharmaceuticals (NRXP) Earnings
View the latest NRX Pharmaceuticals (NRXP) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in NRX Pharmaceuticals (NRXP)
Order type
Buy in
Order amount
Est. shares
0 shares
NRX Pharmaceuticals (NRXP) Earnings per Share (EPS) History
Signup for full accessBrowse free
NRX Pharmaceuticals (NRXP) Latest Earnings
The value each NRXP share was expected to gain vs. the value each share gained.
NRX Pharmaceuticals (NRXP) reported its most recent earnings on Aug 20, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.98. This exceeded analysts' expectations of -$0.23 by 326.09%, marking a Miss.
For comparison, NRX Pharmaceuticals reported EPS of -$0.75 in the same quarter last year.
The company is expected to announce its next earnings report on 11/13/2025, with analysts projecting an EPS of $0.16.
NRX Pharmaceuticals (NRXP) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Nov 17, 2025 | $0.16 | Next earnings call Nov. 13, 2025 | ||
Q2 2025Aug 20, 2025 | -$0.23 | -$0.98 | +326.09% | |
Q1 2025May 15, 2025 | -$0.25 | -$0.34 | +36.00% | |
Q4 2024Mar 17, 2025 | – | -$0.77 | — | |
Q3 2024Nov 18, 2024 | -$0.69 | -$0.15 | -78.26% | |
NRX Pharmaceuticals (NRXP) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the NRX Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 18, 2025 | — | — | — |
May 15, 2025 | — | — | — |
Mar 17, 2025 | — | — | — |
Nov 14, 2024 | — | — | — |
NRX Pharmaceuticals (NRXP) Earnings FAQs
NRX Pharmaceuticals (NRXP) last reported earnings on Aug 20, 2025 for Q2 2025, posting an EPS of -$0.98, which Miss the estimate of -$0.23 by 326.09%.
For Q2 2025, NRX Pharmaceuticals (NRXP) reported an EPS of -$0.98, missing analysts' estimate of -$0.23 by 326.09%.
For Q2 2025, NRX Pharmaceuticals (NRXP) Miss expectations with an actual EPS of -$0.98 vs. an estimated EPS of -$0.23.
Following the last earnings report on Aug 20, 2025, NRX Pharmaceuticals (NRXP)'s stock price moved — from — to —.
The next NRX Pharmaceuticals (NRXP) earnings call is scheduled for Nov. 13, 2025, where executives will discuss financial results and outlook.